Ovid Therapeutics Inc. · NASDAQ:OVID
Eventide Asset Management, LLC reported a 6.30% stake in Ovid Therapeutics Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Eventide Asset Management, LLC reported a 6.30% stake in Ovid Therapeutics Inc., 11,812,241 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 6.30%
- Shares
- 11,812,241
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Eventide Asset Management, LLC | 6.30% | 11,812,241 |
| Finny Kuruvilla, M.D., Ph. D. | 6.30% | 11,812,241 |
| Robin C. John | 6.30% | 11,812,241 |
Source
Related
- Ovid Therapeutics Inc.
- Eventide Asset Management, LLC
- Ovid Therapeutics Inc. shareholders
- Schedule 13G · Eventide Asset Management, LLC · May 15, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026